111 – 120 of 1934
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Carpal Tunnel Syndrome and Diabetes—A Comprehensive Review
(
- Contribution to journal › Scientific review
-
Mark
Real-world data on switching from intravenous to subcutaneous vedolizumab treatment in patients with inflammatory bowel disease
(
- Contribution to journal › Article
-
Mark
Poor intake of vitamins and minerals is associated with symptoms among patients with irritable bowel syndrome
(
- Contribution to journal › Article
-
Mark
Metabolome-Defined Obesity and the Risk of Future Type 2 Diabetes and Mortality
(
- Contribution to journal › Article
-
Mark
Drug-eluting balloon (DEB) versus plain old balloon angioplasty (POBA) in the treatment of failing dialysis access : A prospective randomized trial
(
- Contribution to journal › Article
-
Mark
Blood-brain barrier and gut barrier dysfunction in chronic kidney disease with a focus on circulating biomarkers and tight junction proteins
(
- Contribution to journal › Article
-
Mark
A healthy dietary metabolic signature is associated with a lower risk for type 2 diabetes and coronary artery disease
(
- Contribution to journal › Article
-
Mark
A Starch-and Sucrose-Reduced Diet in Irritable Bowel Syndrome Leads to Lower Circulating Levels of PAI-1 and Visfatin : A Randomized Controlled Study
(
- Contribution to journal › Article
-
Mark
Prostate cancer polygenic risk score and prediction of lethal prostate cancer
(
- Contribution to journal › Article
-
Mark
Editorial: intravenous to subcutaneous vedolizumab—switch without glitch! Authors' reply
2022) In Alimentary Pharmacology and Therapeutics(
- Contribution to journal › Debate/Note/Editorial